Is Fulvestrant Injection in shortage?
Fulvestrant Injection is listed by FDA as being discontinued by at least one maker (updated Aug 14, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Fulvestrant, Injection, 250 mg per 5mL (NDC 63323-715-05)
Discontinuation of the manufacture of the drug
Maker contact: 888-386-1300
FDA recalls of Fulvestrant
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Fulvestrant Injection:
- Zydus Pharmaceuticals (USA) Inc recalls Fulvestrant Injection 250mg/5mL (50 mg/mL), Contains 2 Single-Dose Prefilled Syringes, Rx Only, Product of India,
- Glenmark Pharmaceuticals Inc., USA recalls Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains 2 single-dose pre-filled syringes Rx
Fulvestrant Injection shortage questions
Is Fulvestrant Injection in shortage?
Fulvestrant Injection is listed by FDA as being discontinued by at least one maker (updated Aug 14, 2026).
What should I do if I can’t get Fulvestrant Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.